Navigation Links
The path to new antibiotics
Date:8/27/2009

LA JOLLA, Calif., August 27, 2009 -- Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens. In addition, investigators discovered chemical compounds that can inhibit this enzyme and suppress the growth of pathogenic bacteria. These findings are essential to develop new broad-spectrum antibacterial agents to overcome multidrug resistance. The research was published in the Cell journal Chemistry & Biology on August 27.

Andrei Osterman, Ph.D., an associate professor in Burnham's Bioinformatics and Systems Biology program, and colleagues, targeted the bacterial nicotinate mononucleotide adenylyltransferase (NadD), an essential enzyme for nicotinamide adenine dinculeotide (NAD) biosynthesis. NAD has many crucial functions in nearly all important pathogens and the bacterial NadD differs significantly from the human enzyme.

"It's clear that because of bacterial resistance, we need new, wide-spectrum antibiotics," said Dr. Osterman. "This enzyme is indispensable in many pathogens, so finding ways to inhibit it could give us new options against infection."

According to the National Institutes of Health, drug resistance is making many diseases increasingly difficultand sometimes impossibleto treat. They point to tuberculosis and methicillin-resistant Staphylococcus aureus (MRSA) as two pathogens that pose a serious threat to human health.

Using a structure-based approach, the team searched for low-molecular-weight compounds that would selectively inhibit bacterial NadD, but not the human equivalent, by screening, in silico, more than a million compounds. Experimental testing of the best predicted compounds against Escherichia coli and Bacillus anthracis (anthrax) led them to a handful of versatile inhibitory chemotypes, which they explored in detail. Using protein crystallography, a 3D structure of the enzyme in complex with one of the inhibitors was solved providing guidelines for further drug improvement.

"This is proof-of-concept that NadD is a good target to create antibacterial agents," said Dr Osterman. "This knowledge will be useful for both biodefense and public health. The next step is to find better inhibitors. We do not have a silver bullet yet, but we are certainly hitting a golden target."


'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Burnham Institute
Source:Eurekalert

Related biology news :

1. UIC researchers find promising new targets for antibiotics
2. Alternative methods proposed to detect pesticides and antibiotics in water and natural food
3. Manure management reduces levels of antibiotics and antibiotic resistance genes
4. High degree of resistance to antibiotics in Arctic birds
5. Unique fungal collection could hold key to future antibiotics
6. UIC scientists discover how some bacteria survive antibiotics
7. Class of antibiotics can enhance gene-silencing tool
8. Energy-saving bacteria resist antibiotics
9. Milk may help bacteria survive against low levels of antibiotics
10. New way to make malaria medicine also first step in finding new antibiotics
11. Groundbreaking discovery may lead to stronger antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2019)... ... October 29, 2019 , ... ... kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in ... UA, UTP, and UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using ...
(Date:10/30/2019)... BALTIMORE, Md. (PRWEB) , ... October 30, 2019 ... ... at the 12th Annual CBRNe Convergence in Nashville, TN from Tuesday, November 5, ... and military responses to CBRNe (chemical, biological, radiological, nuclear) and IED (explosive) threats. ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... exhibit self-assembly properties and bioactivity that are encoded by the ordering of ... peptides in the shift of the sidechain attachment to the backbone amide-nitrogen ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 04, 2019 , ... ... development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health ... GPEx® Boost. The technology enhances Catalent’s proven GPEx expression platform through multiple ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial usually ... other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so ... of the latest data, potentially leading to patient risk. , By having a ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer ... South Dakota School of Mines & Technology are exploring new ways to regulate ... , If successful, the technique would prove to be a drug-free, minimally invasive ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November ... , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology ...
Breaking Biology Technology: